Press Releases

 Filter by Provider

GAITHERSBURG, Md., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the quarter and year ended December 31, 2025.

MINNEAPOLIS, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Jefferson Capital, Inc. (NASDAQ: JCAP) (“Jefferson Capital”), a leading analytically driven purchaser and manager of charged-off, insolvency and active consumer accounts, today announced that it will release financial results for the fourth quarter 2025 after the market close on Thursday, March 12, followed by a webcast at 5:00 pm Eastern Time that day to discuss the Company’s results.

SAN JOSE, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Nutanix, Inc. (NASDAQ: NTNX), a leader in hybrid multicloud computing, today announced that its management will present at the following upcoming financial community event:

NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) --  Flutter Entertainment (NYSE:FLUT; LSE:FLTR), the world's leading online sports betting and iGaming operator, announces Q4 and full year 2025 results, and introduces 2026 guidance.

48% Full-Year Revenue Growth and Strong Q4 Results

Initial Phase 1 data of zovegalisib in PIK3CA-driven vascular anomalies expected to be announced in first half of 2026

Company achieves record 7.5 million pounds of PureFive® production in Q4; appoints Donald Carpenter as CFO; progresses Gen-2 design showing path to costs below virgin polypropylene

Earnings Release Highlights

NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Taboola (Nasdaq: TBLA), a global leader in delivering performance at scale for advertisers, today announced that members of its management team will participate in the following investor conferences:

Guides to record Q1 revenue of $185M - $200M, representing year-on-year growth of 57% at the midpoint of the range

Initiates Non-GAAP 30% Rule of 40 Target By the Fourth Quarter of 2027 Approximated Subscription Revenue Contribution for ≥$30K ARR Customers Grew 22% in 2025

REDWOOD CITY, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today reported financial results for the fourth quarter and full year ended December 31, 2025.

Samsung Electronics America, along with entrepreneurs Mark Cuban, Emma Grede and Allison Stransky, hosted the first-ever Samsung Solve for Tomorrow: AI in Action Lab in New York City, bringing together hundreds of students for a hands-on experience designed to turn curiosity about AI into real-world opportunity. Students from A. Philip Randolph Campus High School received education and career advice from Mark Cuban, Emma Grede and Samsung executives, and engaged in an immersive AI in Action Lab co-led by the Mark Cuban Foundation that encouraged students to confidently engage with emerging AI tools and Samsung technology.

Company surpassed $2 billion in GMV, accelerated active buyer growth, and exceeded 2025 financial guidance

Southfield, MI, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Sun Communities, Inc. (NYSE: SUI) (the “Company”), a real estate investment trust ("REIT") that owns and operates, or has an interest in, manufactured housing (“MH”) and recreational vehicle (“RV”) communities, today announced that Charles Young, Chief Executive Officer, will present at the 2026 Citi Global Property CEO Conference in Hollywood, Florida, on Monday, March 2, 2026, at 1:30 p.m. Eastern Standard Time.

Phoenix, AZ - The increasing demand for specialized services for children diagnosed with autism has led to a rise in the need for effective therapy options. In response to this growing need, Children’s Specialized ABA, a trusted provider of Applied Behavior Analysis (ABA) therapy, is expanding its services to Phoenix. This expansion aims to provide families with high-quality, individualized therapy that helps children thrive.

Positive results from the aleniglipron Phase 2 ACCESS programs in December 2025 demonstrated significant weight loss across all doses and up to 15.3% at 36 weeks

SBA Communications Corporation (Nasdaq: SBAC) ("SBA" or the "Company") today reported results for the quarter ended December 31, 2025.

OneSpan Inc. (NASDAQ: OSPN) today reported financial results for the fourth quarter and full year ended December 31, 2025.

Clipper Realty Inc. (NYSE: CLPR) (the “Company”), a leading owner and operator of multifamily residential and commercial properties in the New York metropolitan area, today announced financial and operating results for the three months ended December 31, 2025.

Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to NGN-401, an investigational gene therapy in late-stage clinical development as a potential best-in-class treatment for Rett syndrome.

Definium Therapeutics, Inc. (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today reported its full-year 2025 financial results and provided business updates.

Nerdy Inc. (NYSE: NRDY) today announced financial results for the fourth quarter and year ended December 31, 2025.

NetApp (NASDAQ: NTAP), the Intelligent Data Infrastructure company, today reported financial results for the third quarter of fiscal year 2026, which ended on January 23, 2026.

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today reported financial and operational results for the fourth quarter and full year ended December 31, 2025 and recent business highlights and provided financial guidance for the full year 2026.

Board Authorized New $100 Million Stock Repurchase Plan

Net change in cash and restricted cash of $290 million and Cash Generation1 of $377 million in 2025

Full year 2025 total revenue was $40.5 million, up 7% year-over-year and in line with guidanceFourth quarter 2025 total revenue was $10.0 million, up 8% over the same quarter prior yearCompany provides 2026 revenue guidance of $42-44 million

First of three phases of targeted strategic infrastructure optimization initiative

SOUTH SAN FRANCISCO, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI) today reported financial results for the fourth quarter and full year ended December 31, 2025, and provided business highlights.

BOSTON, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced the closing of its underwritten public offering of 8,581,250 shares of its common stock, and to certain investors that so choose, pre-funded warrants to purchase 2,200,000 shares of its common stock at an exercise price of $0.0001 per share. The shares of common stock sold include 1,406,250 shares pursuant to the option granted by Bicara to the underwriters, which option was exercised in full. The public offering price of each share of common stock was $16.00 and the public offering price of each pre-funded warrant was $15.9999. The aggregate gross proceeds to Bicara from this offering were approximately $172.5 million, before deducting underwriting discounts and commissions and other estimated offering expenses.

Reports Revenue of $318.4 Million, Reflecting Fourth Quarter Growth of 6.7% and 10% for the Full YearGenerated Record $210.2 Million in Full Year Operating Cash FlowReturned Value to Shareholders Through Repurchase of Approximately 6.5 Million Shares To Date Under Recent AuthorizationIssues Financial Guidance for 2026, Reflecting Tenth Consecutive Year of Revenue Growth

BOSTON HEIGHTS, Ohio, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Arhaus, Inc. (“Arhaus” or the “Company”) (NASDAQ: ARHS), a premium home furnishing brand known for responsibly sourced, artisan-crafted products and heirloom-quality design, today announced its participation in the following investor conferences.

Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies, today reported financial results for the fourth quarter and full year ended December 31, 2025, and provided a business update.

VTEX (NYSE: VTEX), the backbone for connected commerce, today announced results for the fourth quarter and fiscal year 2025 ended December 31, 2025. VTEX results have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) as well as the rules and regulations of the Securities and Exchange Commission (“SEC”) regarding financial reporting.

NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Figure Technology Solutions (Nasdaq: FIGR; OPEN: FGRS), the leading blockchain-native capital marketplace for the origination, funding, sale and trading of tokenized assets, today announced financial results for the year and quarter ended December 31, 2025.

– Total revenue of $68.7 million in 4Q25 and $172.4 million in FY2025 – 

WINNIPEG, Manitoba, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS) today announced a series of new contracts and a contract modification with the Public Health Agency of Canada (PHAC) and the Department of National Defence (DND) to deliver critical medical countermeasures to support Canada’s biological threat preparedness and response infrastructure. The multiyear agreements, valued at up to approximately $140 million CAD, build upon over a decade of collaboration between Emergent and Canada and reinforce Canada’s commitment to long-term readiness and advanced strategic stockpiling. Emergent will receive more than $35M million CAD in orders in 2026.

Delivered 41% revenue growth and 83% gross margin in Q4 2025;

— Record-high EXPAREL sales driven by volume growth of 7 percent, marking strongest fourth quarter performance in three years —

VANCOUVER, British Columbia and BOSTON, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and commercialization of life-changing therapeutics for patients in need, today reported financial results for the fourth quarter and full year ended December 31, 2025 and provided a business update.

Announces Authorization of $400 Million Share Repurchase Program

GAITHERSBURG, Md., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that its Board of Directors authorized the repurchase of up to $50 million of the company’s common stock on or before March 31, 2027. This authorization replaces the prior repurchase authorization which permitted Emergent to repurchase up to $50 million of company’s common stock by March 27, 2026. Under the prior authorization, Emergent repurchased $24.8 million shares.

ORANGE, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today reported financial results for its fourth quarter and full year ended Dec. 31, 2025.

NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) --

Mordor Intelligence has published a new report on the Submarine Market, offering a comprehensive analysis of trends, growth drivers, and future projections.

VANCOUVER, BC / ACCESS Newswire / February 26, 2026 / Kidoz Inc. (TSXV:KDOZ)(OTCQB:KDOZF) (the "Company"), a global AdTech platform delivering safe mobile gamer engagement at scale, announced today its unaudited condensed interim financial results for the quarter ended December 31, 2025. All amounts are presented in United States dollars and are in accordance with United States Generally Accepted Accounting Principles.

Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into United Homes Group, Inc.’s (NASDAQ: UHG) board of directors for potential breaches of their fiduciary duties to shareholders in connection with a potential take-private sale of United Homes Group that would cash out every stockholder for $1.18 per share.

Intuit Inc. (Nasdaq: INTU), the global financial technology platform that makes Intuit TurboTax, Credit Karma, QuickBooks, Mailchimp, and Intuit Enterprise Suite, announced financial results for the second quarter of fiscal 2026, which ended January 31.

Aeva® (Nasdaq: AEVA), a leader in next-generation sensing and perception systems, today announced that a top 5 global passenger OEM has selected Aeva for its vehicle development program. The program focuses on the recently introduced Aeva Atlas™ Ultra 4D LiDAR sensor for the OEM’s next-generation global production vehicle platform, and will further refine sensor configuration, integration and performance validation.